| Jenny Shen, | |
|
300 Flynn Ave, Burlington, VT 05401-5301 | |
| (802) 488-6200 | |
| (802) 488-6209 |
| Full Name | Jenny Shen |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 8 Years |
| Location | 300 Flynn Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215399571 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 042.0014824 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Howardcenter, Inc. | 3072403831 | 28 |
News Archive
Tolero Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company developing treatments for oncology and blood disorders, reported positive interim results from an ongoing, randomized Phase 2 clinical trial of its lead drug candidate, alvocidib, in combination with cytarabine plus mitoxantrone for previously untreated acute myeloid leukemia (AML) patients.
Centene Corporation was notified that the Arizona Health Care Cost Containment System has awarded Bridgeway Health Solutions, Centene's Arizona subsidiary, contracts to deliver Arizona Long Term Care System services.
The act of coughing may seem annoying, but for those who can no longer cough on their own because of a medical condition, it's a matter of life and death. Today, more people are surviving brain/spinal cord injuries caused by stroke and automobile accidents.
For more than 10 years, energy drinks in the United States have been on the rise, promising consumers more "oomph" in their day.
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019.
› Verified 6 days ago
| Entity Name | Howardcenter, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639267404 PECOS PAC ID: 3072403831 Enrollment ID: O20041029000184 |
News Archive
Tolero Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company developing treatments for oncology and blood disorders, reported positive interim results from an ongoing, randomized Phase 2 clinical trial of its lead drug candidate, alvocidib, in combination with cytarabine plus mitoxantrone for previously untreated acute myeloid leukemia (AML) patients.
Centene Corporation was notified that the Arizona Health Care Cost Containment System has awarded Bridgeway Health Solutions, Centene's Arizona subsidiary, contracts to deliver Arizona Long Term Care System services.
The act of coughing may seem annoying, but for those who can no longer cough on their own because of a medical condition, it's a matter of life and death. Today, more people are surviving brain/spinal cord injuries caused by stroke and automobile accidents.
For more than 10 years, energy drinks in the United States have been on the rise, promising consumers more "oomph" in their day.
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenny Shen, 300 Flynn Ave, Burlington, VT 05401-5301 Ph: (802) 488-6200 | Jenny Shen, 300 Flynn Ave, Burlington, VT 05401-5301 Ph: (802) 488-6200 |
News Archive
Tolero Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company developing treatments for oncology and blood disorders, reported positive interim results from an ongoing, randomized Phase 2 clinical trial of its lead drug candidate, alvocidib, in combination with cytarabine plus mitoxantrone for previously untreated acute myeloid leukemia (AML) patients.
Centene Corporation was notified that the Arizona Health Care Cost Containment System has awarded Bridgeway Health Solutions, Centene's Arizona subsidiary, contracts to deliver Arizona Long Term Care System services.
The act of coughing may seem annoying, but for those who can no longer cough on their own because of a medical condition, it's a matter of life and death. Today, more people are surviving brain/spinal cord injuries caused by stroke and automobile accidents.
For more than 10 years, energy drinks in the United States have been on the rise, promising consumers more "oomph" in their day.
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019.
› Verified 6 days ago
Rebecca Burch, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4589 | |
Dr. Dhruv Shah, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Judith L Lewis, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Avenue, Fletcher Allen Health Care, Burlington, VT 05401 Phone: 804-847-2791 Fax: 802-847-2733 | |
Ms. Laura Lynn Sponseller, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Fahc Department Of Psychiatry, Patrick 4, Burlington, VT 05401 Phone: 802-829-9645 | |
Lisa Deuel Baker, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4589 | |
Dr. Robert A Pierattini, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4560 Fax: 802-847-8747 | |
Dr. Edward George Boyer Iv, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4589 |